By Heather Caspi
- Aetna has confirmed that beginning June 1, it is moving HIV drugs down from its priciest category of cost sharing, which required members to pay up to half the cost of these expensive drugs, running some members as much as $1,000 per month.
- Following allegations of discrimination from advocates, Aetna is putting the drugs in a category that will run patients between $5 and $100 after their deductibles are met.
- Coventry has announced a similar move, and Humana is reportedly “in the process of developing options to address the high cost of certain specialty drugs” though it hasn’t specified details. Read the full article here. »